Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
Authors
Keywords
Cirrhosis, Diagnosis, Epidemiology, Monitoring, Pharmacological treatment, Type 2 diabetes mellitus
Journal
DIABETES & METABOLISM
Volume 47, Issue 5, Pages 101272
Publisher
Elsevier BV
Online
2021-08-05
DOI
10.1016/j.diabet.2021.101272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis
- (2020) Eduardo Vilar-Gomez et al. Clinical Gastroenterology and Hepatology
- Clinical Performance of Flash Glucose Monitoring System in Patients with Liver Cirrhosis and Diabetes Mellitus
- (2020) Dalila Costa et al. Scientific Reports
- Improvement in Insulin Resistance and Estimated Hepatic Steatosis and Fibrosis after Endoscopic Sleeve Gastroplasty
- (2020) Kaveh Hajifathalian et al. GASTROINTESTINAL ENDOSCOPY
- ESPEN practical guideline: Clinical nutrition in liver disease
- (2020) Stephan C. Bischoff et al. CLINICAL NUTRITION
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESPEN guideline on clinical nutrition in liver disease
- (2019) Mathias Plauth et al. CLINICAL NUTRITION
- Prevalence of diabetes in liver cirrhosis: A systematic review and meta‐analysis
- (2019) Wai Gin Lee et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications
- (2019) A.J. Scheen DIABETES & METABOLISM
- Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
- (2019) Eduardo Vilar-Gomez et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis
- (2019) Chalermrat Bunchorntavakul et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs
- (2019) Awadhesh Kumar Singh et al. Expert Review of Clinical Pharmacology
- Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment
- (2018) Lene Jensen et al. DIABETES OBESITY & METABOLISM
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease
- (2018) Luis C. Bertot et al. LIVER INTERNATIONAL
- Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
- (2018) Chin-Hsiao Tseng LIVER INTERNATIONAL
- Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring
- (2018) Fumi Honda et al. PLoS One
- Effects of Late Evening Snack on Cirrhotic Patients: A Systematic Review and Meta-Analysis
- (2018) Ying-jie Guo et al. Gastroenterology Research and Practice
- Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis
- (2018) Naga S. Addepally et al. DIGESTIVE DISEASES AND SCIENCES
- EASL Clinical Practice Guidelines on nutrition in chronic liver disease
- (2018) Manuela Merli et al. JOURNAL OF HEPATOLOGY
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study
- (2017) Annalisa Berzigotti et al. HEPATOLOGY
- Development of a novel frailty index to predict mortality in patients with end-stage liver disease
- (2017) Jennifer C. Lai et al. HEPATOLOGY
- Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan
- (2017) Dominique Roulot et al. LIVER INTERNATIONAL
- Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
- (2017) Yan Zheng et al. Nature Reviews Endocrinology
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
- (2017) Rury R Holman et al. Lancet Diabetes & Endocrinology
- Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease
- (2016) S. Petta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus
- (2016) S. Gentile et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis
- (2016) Luis Calzadilla-Bertot et al. DIGESTIVE AND LIVER DISEASE
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
- (2016) Emanuela Orsi et al. LIVER INTERNATIONAL
- Diabetes mellitus in patients with cirrhosis: clinical implications and management
- (2016) Laure Elkrief et al. LIVER INTERNATIONAL
- Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study
- (2016) George Boon-Bee Goh et al. LIVER INTERNATIONAL
- Frequency and characteristics of diabetes in 300 pre-liver transplant patients
- (2016) L. Marselli et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
- (2016) Jeffrey Nadelson et al. International Journal of Endocrinology
- Alcohol consumption reduces HbA1c and glycated albumin concentrations but not 1,5-anhydroglucitol
- (2016) Shinya Inada et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Pharmacokinetics, Pharmacodynamics and Clinical Use of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
- (2015) André J. Scheen CLINICAL PHARMACOKINETICS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Predictors for Mild and Severe Hypoglycemia in Insulin-Treated Japanese Diabetic Patients
- (2015) Nao Sonoda et al. PLoS One
- Alogliptin: Concern About Hepatotoxicity?
- (2014) André J. Scheen CLINICAL PHARMACOKINETICS
- Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease
- (2014) André J Scheen Expert Opinion on Drug Metabolism & Toxicology
- Rationale for conducting a randomized trial to examine the efficacy of metformin in improving survival in cirrhosis: Pleiotropic effects hypothesis
- (2014) Rohit Loomba HEPATOLOGY
- Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
- (2014) Xiaodan Zhang et al. HEPATOLOGY
- Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C
- (2014) Laure Elkrief et al. HEPATOLOGY
- Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis
- (2014) Diego García-Compeán WORLD JOURNAL OF GASTROENTEROLOGY
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment
- (2013) Viera Kupčová et al. CLINICAL DRUG INVESTIGATION
- Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment
- (2013) S. Macha et al. DIABETES OBESITY & METABOLISM
- Pharmacokinetics of linagliptin in subjects with hepatic impairment
- (2012) Ulrike Graefe-Mody et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and Safety Profile Evaluation of Acarbose Alone and in Association With Other Antidiabetic Drugs: A Systematic Review
- (2012) Giuseppe Derosa et al. CLINICAL THERAPEUTICS
- Mechanisms Involved in the Protective Effects of Metformin Against Nonalcoholic Fatty Liver Disease
- (2012) V. J. Barbero-Becerra et al. CURRENT MEDICINAL CHEMISTRY
- Repaglinide
- (2012) Lesley J. Scott DRUGS
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
- (2012) Javier Ampuero et al. PLoS One
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
- (2011) David W. Boulton et al. CLINICAL PHARMACOKINETICS
- Clinical Pharmacokinetics of Metformin
- (2011) Garry G. Graham et al. CLINICAL PHARMACOKINETICS
- Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study
- (2011) Sreeneeranj Kasichayanula et al. CLINICAL THERAPEUTICS
- Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
- (2011) Gisèle Nkontchou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide
- (2010) Anne Flint et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Continuous Subcutaneous Insulin Infusion (Insulin Pump) in Reducing Blood Glucose in Four Patients with Type 2 Diabetes and Cirrhosis: A Case Series
- (2010) Johny J. Kannampilly Diabetes Technology & Therapeutics
- Lactic Acidosis Induced by Metformin
- (2010) Jean-Daniel Lalau DRUG SAFETY
- Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
- (2010) Valter Donadon et al. LIVER INTERNATIONAL
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alcohol and type 2 diabetes. A review
- (2010) A. Pietraszek et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management
- (2009) Diego Garcia-Compean et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects?
- (2008) Luis Aparisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More